Market Value1,730,387,000
Total Holdings64
File Date2020-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KDNY / Chinook Therapeutics Inc
FIXX / Homology Medicines, Inc.
CBAY / CymaBay Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
AVDL / Avadel Pharmaceuticals plc
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
OVID / Ovid Therapeutics Inc.
US62857M1053 / MyoKardia, Inc.
PSTX / Poseida Therapeutics, Inc.
ZYME / Zymeworks Inc.
KALV / KalVista Pharmaceuticals, Inc.
ALXO / ALX Oncology Holdings Inc.
AKRO / Akero Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
CLTEF / Clara Technologies Corp.
SAGE / Sage Therapeutics, Inc.
SVA / Sinovac Biotech, Ltd.
ARQT / Arcutis Biotherapeutics, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
ZGNX / Zogenix Inc
INSM / Insmed Incorporated
RVMD / Revolution Medicines, Inc.
MEIP / MEI Pharma, Inc.
ETNB / 89bio, Inc.
GLMD / Galmed Pharmaceuticals Ltd.
VYNE / VYNE Therapeutics Inc.
VSTM / Verastem, Inc.
NVAX / Novavax, Inc.
AVRO / AVROBIO, Inc.
CYTK / Cytokinetics, Incorporated
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
NFH / New Frontier Health Corporation - Class A
MTCR / Metacrine Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SRRA / Sierra Oncology Inc
NKTX / Nkarta, Inc.
MTNB / Matinas BioPharma Holdings, Inc.
KURA / Kura Oncology, Inc.
BDTX / Black Diamond Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
SELB / Selecta Biosciences Inc
LRMR / Larimar Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
AUPH / Aurinia Pharmaceuticals Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
KNSA / Kiniksa Pharmaceuticals, Ltd.
CVAC / CureVac N.V.
PASG / Passage Bio, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
IMVT / Immunovant, Inc.
IGMS / IGM Biosciences, Inc.
KALA / KALA BIO, Inc.
ATRC / AtriCure, Inc.
KDMN / Kadmon Holdings Inc
ATHA / Athira Pharma, Inc.
ACRS / Aclaris Therapeutics, Inc.
TCDA / Tricida Inc
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
HRMY / Harmony Biosciences Holdings, Inc.
DTIL / Precision BioSciences, Inc.
AMRS / Amyris Inc
CRNX / Crinetics Pharmaceuticals, Inc.
CDXS / Codexis, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)